Chemical Component Summary | |
---|---|
Name | SPARSOMYCIN |
Identifiers | (E)-N-[(2S)-1-hydroxy-3-[(R)-methylsulfanylmethylsulfinyl]propan-2-yl]-3-(4-methyl-2,6-dioxo-3H-pyrimidin-5-yl)prop-2-enamide |
Formula | C13 H19 N3 O5 S2 |
Molecular Weight | 361.437 |
Type | NON-POLYMER |
Isomeric SMILES | CC1=C(C(=O)NC(=O)N1)/C=C/C(=O)N[C@@H](CO)C[S@@](=O)CSC |
InChI | InChI=1S/C13H19N3O5S2/c1-8-10(12(19)16-13(20)14-8)3-4-11(18)15-9(5-17)6-23(21)7-22-2/h3-4,9,17H,5-7H2,1-2H3,(H,15,18)(H2,14,16,19,20)/b4-3+/t9-,23+/m0/s1 |
InChIKey | XKLZIVIOZDNKEQ-CLQLPEFOSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 42 |
Chiral Atom Count | 2 |
Bond Count | 42 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB04222 |
---|---|
Name | Sparsomycin |
Groups | experimental |
Description | An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem] |
Synonyms |
|
Categories |
|
CAS number | 1404-64-4 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 9543443 |
ChEMBL | CHEMBL105720 |